Publications: Treatment 2.0
2012
-
WHO informal consultation on medium- and long-term priorities for ARV drug optimization
Moving towards simplification, harmonization and universal access
1 October 2012 -
Report of the meeting of the paediatric working group developing an optimized list of paediatric ARV formulations
Interagency Task Team on prevention and treatment of HIV infection in pregnant women, mothers and their children (5 May 2011, Switzerland)
1 September 2012 -
Developing dosing guidance for new and upcoming formulations of paediatric ARVs in line with Treatment 2.0 priorities
Report of the meeting of the Antiretroviral Working Group (25-26 October 2011)
1 August 2012 -
The strategic use of antiretrovirals to help end the HIV epidemic
18 July 2012 -
Use of tenofovir in HIV-infected children and adolescents: A public health perspective
Technical update on treatment optimization
26 June 2012 -
Pharmacological equivalence and clinical interchangeability of lamivudine and emtricitabine: a review of current literature
Technical update on treatment optimization
21 June 2012 -
Use of efavirenz during pregnancy: A public health perspective
Technical update on treatment optimization
1 June 2012 -
WHO expert meeting on short-term HIV diagnosis, treatment initiation and monitoring technologies and approaches
Meeting report (3-14 October 2011, Geneva, Switzerland)
1 May 2012 -
Retention in HIV programmes: Defining the challenges and identifying solutions
Meeting report (13-15 September 2011, Geneva, Switzerland)
1 May 2012
2011
-
The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support
15 July 2011 -
Treatment 2.0 at-a-glance
15 July 2011 -
Short-term priorities for antiretroviral drug optimization
Meeting report (18 – 19 April 2011, London, UK)
15 July 2011 -
Treatment 2.0: Catalysing the next phase of scale-up
The Lancet comment
25 February 2011
